Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

Safety and Efficacy of A-007 Topical Gel in the Treatment of High-Grade Squamous Intraepithelial Lesions (HSIL) of the Cervix

ClinicalTrials.gov ID: NCT00285207

Public ClinicalTrials.gov record NCT00285207. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 21, 2026, 3:31 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Trial of the Use of 4,4'-Dihydroxybenzophenone-2,4-Dinitrophenyl-hydrazone (A-007) Topical Gel in the Treatment of High-Grade Squamous Intraepithelial Lesions (HSIL) of the Cervix

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

A-007 is an investigational therapy which may be effective in the treatment of pre-cancerous cervical dysplasia (abnormal cell growth). The purpose of this study is to evaluate the safety and efficacy of A-007, when used to treat high-grade cervical dysplasia.

Study identification

NCT ID
NCT00285207
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Tigris Pharmaceuticals
Industry
Enrollment
147 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
Female
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jan 2006 (Type not available)
Primary completion
Apr 2008 (Actual)
Completion
Jun 2008 (Actual)
Last update posted
Oct 11, 2010

2006 – 2008

United States locations

U.S. sites
29
U.S. states
16
U.S. cities
28
Facility City State ZIP Site status
University of Alabama Highlands, Dept. of OB/GYN Birmingham Alabama 35205 —
Hope Research Institute, LLC Phoenix Arizona 85032 —
Visions Clinical Research-Tucson Tucson Arizona 85712 —
Northern California Research Corp Carmichael California 95608 —
Arrowhead Regional Medical Center Colton California 92324 —
Robin Black OGNP Costa Mesa California 92629 —
IGO Medical Group of San Diego San Diego California 92121 —
Coastal Connecticut Research, LLC New London Connecticut 06320 —
Washington Hospital Center Washington D.C. District of Columbia 20010 —
Visions Clinical Research Boynton Beach Florida 33437 —
Global OB/GYN Centers of Florida Pembroke Pines Florida 33024 —
Physician Care Clinical Research, LLC. Sarasota Florida 34239 —
OB/GYN Specialists of the Palm Beaches West Palm Beach Florida 33401 —
Mount Vernon Clinical Research, LLC Atlanta Georgia 30328 —
Medical College of Georgia Augusta Georgia 30912 —
East Jefferson OB/GYN Metairie Louisiana 70006 —
Office of R. Garn Mabey, MD Las Vegas Nevada 89128 —
Jersey Shore University Medical Center Neptune City New Jersey 07754 —
New York Downtown Hospital New York New York 10038 —
Jacobi Medical Center The Bronx New York 10461 —
Montefiore Medical Center-Weiler Division Dept of OB/GYN & Women's Health The Bronx New York 10461 —
Greater Cincinnati OB/GYN, Inc. Cincinnati Ohio 45267 —
University of Oklahoma Health Sciences Center Dept of OB/GYN Oklahoma City Oklahoma 73104 —
Lehigh Valley Hospital Allentown Pennsylvania 18102 —
Magee-Womens Hospital, Dept of OB/GYN & Reproductive Services Pittsburgh Pennsylvania 15213 —
South Carolina Oncology Associates Columbia South Carolina 29210 —
Hill Country OB/GYN Austin Texas 78737 —
Planned Parenthood of Houston & Southeast Texas, Inc. Houston Texas 77004 —
4601 Old Shepard Place; Bldg 2, Suite 201 Plano Texas 75093 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00285207, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Oct 11, 2010 · Synced Oct 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00285207 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →